Clinical Trial Update: MAGIA H3S Point of Care Test Performance for HIV, HBV, HCV, and Syphilis Screening in Pregnant Women in DR Congo

View source ↗

Summary

The trial update describes the MAGIA H3S point-of-care test being evaluated for HIV, hepatitis B and C, and syphilis screening in pregnant women in the DR Congo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Hepatitis B
• Hepatitis C
• Syphilis

Drugs mentioned

• MAGIA H3S Point of Care Test

Snippet

Sponsor: Gardiens de Vies | Conditions: HIV - Human Immunodeficiency Virus, HBV (Hepatitis B Virus) | Status: NOT_YET_RECRUITING